Bon Park

机构：Samsung (South Korea), Sungkyunkwan University · ORCID：0009-0001-7012-1065

发表论文 12 篇 · 总被引 61 次 · h-index 5

代表论文

• Circulating Tumor DNA–Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas (2022 · Cancer Research and Treatment · 被引 21)
• Clinical relevance of serum-derived exosomal messenger RNA sequencing in patients with non-Hodgkin lymphoma (2022 · Journal of Cancer · 被引 10)
• Efficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphoma (2025 · Blood · 被引 9)
• Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma (2022 · Cancers · 被引 9)
• Feasibility of Circulating Tumor DNA Detection in the Cerebrospinal Fluid of Patients With Central Nervous System Involvement in Large B-Cell Lymphoma (2024 · Annals of Laboratory Medicine · 被引 5)
• Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma (2024 · Experimental Cell Research · 被引 5)